Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Biopejs-shop.dk ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.4% 2.9% 3.2% 1.3% 1.5% 1.5% 5.8% 5.3%   Credit score (0-100)   55 58 54 79 75 77 40 42   Credit rating   BBB BBB BBB A A A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 231.0 116.5 129.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,148 5,984 10,446 12,073 14,813 14,629 0.0 0.0   EBITDA   436 1,596 5,952 6,790 8,311 7,663 0.0 0.0   EBIT   360 1,506 5,800 6,515 8,031 7,340 0.0 0.0   Pre-tax profit (PTP)   347.0 1,510.7 5,776.2 6,479.5 8,061.7 7,463.3 0.0 0.0   Net earnings   262.9 1,176.9 4,499.5 5,049.3 6,271.8 5,808.0 0.0 0.0   Pre-tax profit without non-rec. items   347 1,511 5,776 6,480 8,062 7,463 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   700 733 1,450 1,175 943 2,004 0.0 0.0   Shareholders equity total   1,618 2,687 6,966 11,788 16,560 21,368 11,288 11,288   Interest-bearing liabilities   236 229 90.5 54.3 737 92.8 0.0 0.0   Balance sheet total (assets)   3,172 4,839 10,797 18,007 22,380 26,287 11,288 11,288   Net Debt   207 -723 -2,745 -6,344 -3,932 -5,461 -11,182 -11,182     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,148 5,984 10,446 12,073 14,813 14,629 0.0 0.0   Gross profit growth   18.2% 44.3% 74.6% 15.6% 22.7% -1.2% -100.0% 0.0%   Employees   12 12 11 12 12 12 0 0   Employee growth %   9.1% 0.0% -8.3% 9.1% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,172 4,839 10,797 18,007 22,380 26,287 11,288 11,288   Balance sheet change%   -8.4% 52.6% 123.1% 66.8% 24.3% 17.5% -57.1% 0.0%   Added value   435.6 1,596.1 5,952.1 6,790.2 8,306.0 7,662.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -35 -57 564 -550 -330 662 -2,004 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.7% 25.2% 55.5% 54.0% 54.2% 50.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.2% 37.9% 74.2% 45.3% 39.9% 30.7% 0.0% 0.0%   ROI %   18.4% 59.9% 112.9% 68.6% 55.2% 38.5% 0.0% 0.0%   ROE %   17.1% 54.7% 93.2% 53.8% 44.2% 30.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   51.0% 55.5% 66.4% 67.8% 74.8% 81.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   47.5% -45.3% -46.1% -93.4% -47.3% -71.3% 0.0% 0.0%   Gearing %   14.6% 8.5% 1.3% 0.5% 4.4% 0.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.6% 2.6% 14.9% 53.4% 0.7% 3.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.3 1.1 1.5 1.9 2.7 3.0 0.0 0.0   Current Ratio   1.6 2.2 2.5 2.7 5.2 6.9 0.0 0.0   Cash and cash equivalent   29.3 951.7 2,835.1 6,398.5 4,668.3 5,553.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   958.3 2,204.7 5,571.6 10,657.6 17,122.3 20,680.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   36 133 541 566 692 639 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   36 133 541 566 693 639 0 0   EBIT / employee   30 126 527 543 669 612 0 0   Net earnings / employee   22 98 409 421 523 484 0 0